Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily licensed for the management of type 2 diabetes mellitus and, in specific cases, for weight management
Additionally, exendin 939 administration mitigated paw swelling resulting from CFA induction (Supplementary Fig
Regional Analysis North America is leading the Anti-obesity Drugs Market In 2024, North America accounted for a 46.4% share of the anti-obesity drugs market, driven by high obesity prevalence, advanced healthcare infrastructure, and substantial healthcare expenditure
Top products Skin Biology 7% GHK-Cu Accelerant Serum with 4 ingredients, including peptides
Merck, Argentina), and/or corifollitropin alpha (Elonva